TABLE 2.
Benign n = 32 (71) |
Malignant n = 13 (29) |
p value | |
---|---|---|---|
Age at surgery (years) | 59 (41–80) | 68 (50–89) | < 0.05 |
Female | 19 (59) | 6 (46) | 0.42 |
Race | |||
Caucasian/White | 20 (63) | 12 (92) | < 0.05 |
African-American/Black | 12 (37) | 1 (8) | < 0.05 |
Body mass index (kg/m2) | 28.3 (17.9–44.7) | 26.6 (18.4–37.1) | 0.83 |
Alcohol use within the last 5 yearsa | 2 (6) | 3 (23) | 0.10 |
Tobacco use within the last 5 yearsb | 5 (16) | 2 (15) | 0.98 |
Age-adjusted Charlson index | 2 (0–7) | 4 (1–7) | 0.05 |
Preoperative biliary stent | 3 (9) | 6 (46) | < 0.01 |
Asymptomatic at diagnosis | 12 (38) | 2 (15) | 0.15 |
High-grade dysplasia on biopsy | 7 (22) | 5 (38) | 0.25 |
Tumor size (mm) | 35 (4–100) | 25 (10–50) | < 0.05 |
Pancreatic duct (mm) | 2.71 (± 0.97) | 2.85 (± 0.80) | 0.66 |
Bile duct (mm) | 7.52 (± 3.19) | 12.31 (± 4.64) | < 0.01 |
Estimated blood loss (ml) | 100 (20–700) | 200 (25–600) | 0.78 |
Length of surgery (min) | 193 (109–480) | 172 (125–397) | 0.18 |
Major complicationsc | 14 (44) | 0 (0) | < 0.01 |
Postoperative pancreatic fistula | 7 (22) | 1 (8) | 0.26 |
Grade C | 4 (13) | 0 (0) | 0.18 |
Length of stay (days) | 9 (2–90) | 7 (5–12) | < 0.05 |
Readmission | 6 (19) | 2 (15) | 0.79 |
Patient death | 3 (9) | 0 (0) | 0.36 |
Continuous variables are expressed as median (range); categorical variables are expressed as n (%) Bold values denote p values < 0.05
Alcohol use is defined as > 3 drinks/day or > 7 drinks/week for women and > 4 drinks/day or > 14 drinks/week for men (National Institute on Alcohol Abuse and Alcoholism)
Tobacco use is defined as daily use of any tobacco product (Substance Abuse and Mental Health Services Administration)
Major complications (Clavien–Dindo grade ≥ III)